Efficacy of Alfacalcidol and Alendronate on Lumbar Bone Mineral Density in Osteoporotic Patients Using Proton Pump Inhibitors

Biomedical Reports - Greece
doi 10.3892/br.2016.710
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Effects of Combined Treatment With Alendronate and Alfacalcidol on Bone Mineral Density and Bone Turnover in Postmenopausal Osteoporosis: A Two-Years, Randomized, Multiarm, Controlled Trial

The Internet Journal of Epidemiology
2007English

Effects of Zoledronic Acid on Bone Fusion in Osteoporotic Patients After Lumbar Fusion

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2015English

E0434 the Effects of Proton Pump Inhibitors on Clopidogrel Efficacy in Patients With ACS Through PCI in China

Heart
Cardiovascular MedicineCardiology
2010English

Efficacy and Safety of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients Taking Proton Pump Inhibitors

Journal of Clinical and Translational Hepatology
2017English

Proton Pump Inhibitors and Risk of Vitamin and Mineral Deficiency: Evidence and Clinical Implications

Therapeutic Advances in Drug Safety
Pharmacology
2013English

Evaluation of Bone Mineral Density in Hemodialysis Patients

FTR - Turkiye Fiziksel Tip ve Rehabilitasyon Dergisi
Physical TherapySports TherapyRehabilitation
2010English

Proton Pump Inhibitors in Kidney Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Proton Pump Inhibitors and Gastric Neoplasia

Gut
Gastroenterology
2006English

The Persistence of Lumbar Somatic Dysfunction and Its Association With Bone Mineral Density

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy